Down 62%. Should You Buy TransMedics Stock on the Dip?
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August.The company's warm perfusion devices are the only ones approved by the Food and Drug Administration (FDA) to transport and store multiple solid organs. TransMedics is also the only solid organ transport device maker with a fleet of jets dedicated to transporting donated organs.Unfortunately, TransMedics isn't the only company selling FDA-approved warm perfusion devices. Here's a look at what caused the company to forecast a sales slowdown to see if it could be a good stock to buy now.Continue reading
It's been a rough several months for TransMedics Group (NASDAQ: TMDX) shareholders. The stock has been beaten down by about 62% from the peak it set last August.
The company's warm perfusion devices are the only ones approved by the Food and Drug Administration (FDA) to transport and store multiple solid organs. TransMedics is also the only solid organ transport device maker with a fleet of jets dedicated to transporting donated organs.
Unfortunately, TransMedics isn't the only company selling FDA-approved warm perfusion devices. Here's a look at what caused the company to forecast a sales slowdown to see if it could be a good stock to buy now.
